Alpha-2-macroglobulin intronic polymorphism is not associated with autopsy-confirmed late-onset Alzheimer's disease

Neuroscience Letters

Volumn 273, Issue 1, 1999, Pages 61-63

  Kovács, Tibor ^a,b   Cairns, Nigel J ^a,c   Lantos, Peter L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Alpha 2 macroglobulin; Alzheimer's disease; Apolipoprotein E

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CONTROLLED STUDY; GENE FREQUENCY; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; INTRON; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

AGE OF ONSET; AGED; ALLELES; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; APOLIPOPROTEINS E; AUTOPSY; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; POLYMORPHISM, GENETIC;

EID: 0032831866     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00604-7     Document Type: Article

References (12)

1. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson B. Jr, Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:1998;357-360.
2. Cairns N.J., Atkinson P.A., Kovàcs T., Lees A.J., Daniel S.A., Lantos P.L. Apolipoprotein E ε4 allele frequency in patients with multiple system atrophy. Neurosci. Lett. 221:1997;161-164.
3. Dow D.J., Lindsey N., Cairns N.J., Brayne C., Robinson D., Huppert F.A., Paykel E.S., Xuereb J., Wilcock G., Whittaker J.L., Rubinsztein D.C. α-2 macroglobulin polymorphism and Alzheimer disease risk in the UK. Nat. Genet. 22:1999;16-17.
4. Levy-Lahad E., Bird T.D. Genetic factors in Alzheimer's disease: a review of recent advances. Ann. Neurol. 40:1996;829-840.
5. Matthijs G., Marynen P. A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene. Nucl. Acids Res. 19:1991;5102.
6. Mayeux R., Ottman R. Alzheimer's disease genetics: home runs and strikeouts. Ann. Neurol. 44:1998;716-719.
7. Mirra, S.S., Heyman, A., McKeel, D., Sumi, S.M., Crain, B.J., Brownlee, L.M., Vogel, F.S., Hughes, J.P., van Belle, Participating CERAD neuropathologists, B., The consortium to establish a registry for Alzheimer's disease (CERAD): Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology. 41 (1991) 479-486.
8. Narita M., Holtzman D.M., Schwartz A.L., Bu G. Alpha-2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69:1997;1904-1911.
9. Rogaeva E.A., Premkumar S., Grubber J., Serneels L., Scott W.K., Kawarai T., Song Y., Hill D.L.M., Abou-Donia S.M., St. George-Hyslop P.H., Farrer L.A., Pericak-Vance M.A. An α-2 macroglobulin insertion-deletion polymorphism in Alzheimer disease. Nat. Genet. 22:1999;19-21.
10. Rudrasingham V., Wavrant-De Vriéze F., Lambert J-C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Rice F., Pérez-Tur J., Frigard B., Morris J.C., Carty S., Petersen R., Cottel D., Tunstall N., Holmans P., Lovestone S., Chartier-Harlin M.-C., Goate A., Hardy J., Owen M.J., Williams J. α-2 macroglobulin gene and Alzheimer disease. Nat. Genet. 22:1999;17-19.
11. Saunders A.M., Strittmatter W.J., Schmechel D., St. George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R, Alberts M.J, Hulette C, Crain B, Goldgaber D., Roses A.D. Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
12. Tierney M.C., Fisher R.H., Lewis A.J., Zorzitto M.L., Snow W.G., Reid D.W., Nieuwstaten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathological study of 57 cases. Neurology. 38:1988;359-364.